Skip to main content

Type at least 3 characters

27,906 articles

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Original Research

Published on 04 Nov 2022

Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung

in Inflammation

Yoko Miura
Hirotsugu Ohkubo
Akiko Nakano
Jane E. Bourke
Satoshi Kanazawa

Frontiers in Immunology

doi 10.3389/fimmu.2022.1028613

4,397 views
7 citations

Editorial

Published on 04 Nov 2022

Editorial: Molecular switches of the immune system: The E-protein/Id axis in hematopoietic development and function

in T Cell Biology

Mikael Sigvardsson
Barbara L. Kee
Juan Carlos Zúñiga-Pflücker
Michele K. Anderson

Frontiers in Immunology

doi 10.3389/fimmu.2022.1062734

1,875 views

Original Research

Published on 04 Nov 2022

Relationships of circulating CD4+ T cell subsets and cytokines with the risk of relapse in patients with Crohn’s disease

in Mucosal Immunity

Rémi Duclaux-Loras
Gilles Boschetti
Bernard Flourie
Xavier Roblin
Jean-Benoit Leluduec
Stéphane Paul
Thibaut Almeras
Karine Ruel
Anthony Buisson
Jacques Bienvenu

Frontiers in Immunology

doi 10.3389/fimmu.2022.864353

2,846 views
3 citations

Original Research

Published on 04 Nov 2022

Identifying hub genes of calcific aortic valve disease and revealing the immune infiltration landscape based on multiple WGCNA and single-cell sequence analysis

in Systems Immunology

Kan Wang
Qiang Zheng
Xing Liu
BingChuan Geng
NianGuo Dong
JiaWei Shi

Frontiers in Immunology

doi 10.3389/fimmu.2022.1035285

18,313 views
9 citations

Editorial

Published on 04 Nov 2022

Editorial: Epigenetics of infectious diseases

in Microbial Immunology

Smita Kulkarni
Thilona Arumugam
Anil Chuturgoon
Ping An
Veron Ramsuran

Frontiers in Immunology

doi 10.3389/fimmu.2022.1054151

3,595 views
8 citations

Original Research

Published on 04 Nov 2022

Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs

in Molecular Innate Immunity

Lisa Hurler
Erik J. M. Toonen
Erika Kajdácsi
Bregje van Bree
Ricardo J. M. G. E. Brandwijk
Wieke de Bruin
Paul A. Lyons
Laura Bergamaschi
Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration
György Sinkovits

Frontiers in Immunology

doi 10.3389/fimmu.2022.1039765

9,720 views
19 citations

Editorial

Published on 04 Nov 2022

Editorial: The role of immune cells in hepatic ischemia reperfusion

in Molecular Innate Immunity

Bibo Ke
Helong Dai
Qiang Wei
Zhiyong Guo
Tao Qiu

Frontiers in Immunology

doi 10.3389/fimmu.2022.1075984

2,770 views
3 citations

Original Research

Published on 04 Nov 2022

Mesenchymal stromal cell extracellular vesicles for multiple sclerosis in preclinical rodent models: A meta-analysis

in Multiple Sclerosis and Neuroimmunology

Chengfeng Xun
Huiyin Deng
Jing Zhao
Lite Ge
Zhiping Hu

Frontiers in Immunology

doi 10.3389/fimmu.2022.972247

4,339 views
13 citations

Original Research

Published on 03 Nov 2022

Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis

in Cytokines and Soluble Mediators in Immunity

Javier Marín-Prida
Nancy Pavón-Fuentes
Nielsen Lagumersindez-Denis
Hanlet Camacho-Rodríguez
Ana Margarita García-Soca
Rocío de la Caridad Sarduy-Chávez
Érica Leandro Marciano Vieira
Juliana Carvalho-Tavares
Viviana Falcón-Cama
Julio Raúl Fernández-Massó

Frontiers in Immunology

doi 10.3389/fimmu.2022.1036200

5,971 views
11 citations

Original Research

Published on 03 Nov 2022

Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic target: A bulk omics research and single cell sequencing validation

in Cancer Immunity and Immunotherapy

Yan Qin
Jie Yang
Cao Liang
Jun Liu
Zhixing Deng
Binli Yan
Ying Fu
Yinghua Luo
Xiaozhen Li
Xiaoying Wei

Frontiers in Immunology

doi 10.3389/fimmu.2022.994828

14,808 views
30 citations

Original Research

Published on 03 Nov 2022

Low dose versus standard dose rituximab for the treatment of antiphospholipid syndrome: A pilot study from a tertiary medical center

in Autoimmune and Autoinflammatory Disorders

Yuzhou Gan
Xue Zhong
Yawei Zhao
Gongming Li
Hua Ye
Chun Li

Frontiers in Immunology

doi 10.3389/fimmu.2022.971366

4,655 views
6 citations

Original Research

Published on 03 Nov 2022

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer

in Vaccines and Molecular Therapeutics

Mathieu J. F. Crupi
Zaid Taha
Thijs J. A. Janssen
Julia Petryk
Stephen Boulton
Nouf Alluqmani
Anna Jirovec
Omar Kassas
Sarwat T. Khan
Sydney Vallati

Frontiers in Immunology

doi 10.3389/fimmu.2022.1029269

11,067 views
23 citations

Original Research

Published on 03 Nov 2022

Moving the needle: Employing deep reinforcement learning to push the boundaries of coarse-grained vaccine models

in Systems Immunology

Jonathan G. Faris
Daniel Orbidan
Charles Wells
Brenden K. Petersen
Kayla G. Sprenger

Frontiers in Immunology

doi 10.3389/fimmu.2022.1029167

3,619 views
7 citations

Review

Published on 03 Nov 2022

Mast cells as important regulators in the development of psoriasis

in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders

Xu-Yue Zhou
Kun Chen
Jia-An Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2022.1022986

7,945 views
21 citations

Original Research

Published on 03 Nov 2022

Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19

in Viral Immunology

Martijn Zoodsma
Aline H. de Nooijer
Inge Grondman
Manoj Kumar Gupta
Agnes Bonifacius
Valerie A. C. M. Koeken
Emma Kooistra
Gizem Kilic
Ozlem Bulut
Nina Gödecke

Frontiers in Immunology

doi 10.3389/fimmu.2022.1027122

7,786 views
25 citations

Original Research

Published on 03 Nov 2022

Association between immune-mediated adverse events and efficacy in metastatic non-small-cell lung cancer patients treated with durvalumab and tremelimumab

in Cancer Immunity and Immunotherapy

Agnish Dey
Matthew Austin
Harriet M. Kluger
Nataliya Trunova
Helen Mann
Norah Shire
Claire Morgan
Diansong Zhou
Ganesh M. Mugundu

Frontiers in Immunology

doi 10.3389/fimmu.2022.1026964

4,123 views
4 citations